Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

What Are Some Concerns Regarding Pre-Exposure Prophylaxis Treatment?

JUN 14, 2017 | CONTAGION® EDITORIAL STAFF


Kenneth Mayer, MD, Medical Research Director, Professor of Medicine, Fenway Health, Harvard University, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.

Interview Transcript (slightly modified for readability)

“Pre-exposure prophylaxis is the use of antiretroviral medications to protect people against HIV; it’s shown to be effective if people are adherent. So, the concerns are some people might be prescribed this and not be adherent, and they could become infected, [and] not have adequate drug levels on board but select for drug resistance. Others have concerns just about the idea of giving medication to people who are otherwise healthy, but we think of this as a very important way to prevent HIV.”
 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.